Hybrid Conferencee

International Symposium on Oncology, Immunotherapy and Biomarkers (ISOIB - 27)

17th - 18th March 2027 | Pretoria, South Africa
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Expand the Academic Reach of Your Research - a Q1-ranked and Scopus-indexed journal publication opportunity

Journal consideration and publication are subject to editorial review, peer review and applicable journal policies.

Conference Notifications:

"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."

Call for Papers Extended:
"The deadline for full paper submissions has been extended for the Research Plus International Conference in Pretoria. Submit your research by today to participate in one of the top conferences."
Certificate of Presentation:
"Present your research and receive a Certificate of Presentation to recognise your valuable contribution to the conference."
Abstract Submissions Open:
"Abstract submissions for the Pretoria event are now open! Don’t miss the chance to present your research. Submit now."
Networking with Global Experts:
"Engage with researchers and professionals from around the world at the Pretoria conference. Build collaborations and gain insights from leading experts."
Keynote Speaker Sessions:
"Don’t miss our Keynote Sessions in Pretoria, featuring global leaders and innovators sharing their knowledge."
Best Paper & Best Paper Presentation Award:
"Submit your paper and stand a chance to win the Best Paper Presentation Award. The winner will be recognized at the conference in Pretoria."
SDG-Inspired Conference Focus:
"Our conference will highlight research that addresses global sustainability, inclusive education, and solutions for environmental challenges."

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3
SDG 3 Good Health and Well-being
SDG 4
SDG 4 Quality Education
SDG 9
SDG 9 Industry, Innovation and Infrastructure
Track 01

Advancements in Immunotherapy for Cancer Treatment

This track will explore the latest breakthroughs in immunotherapy, focusing on novel therapeutic agents and their mechanisms of action. Discussions will include clinical trial outcomes and the integration of immunotherapy into standard cancer treatment protocols.

Track 02

Biomarkers in Cancer Diagnosis and Prognosis

This session will delve into the role of biomarkers in enhancing cancer diagnosis and predicting patient outcomes. Researchers will present findings on the identification and validation of biomarkers across various cancer types.

Track 03

Precision Medicine in Oncology

This track will examine the principles and applications of precision medicine in oncology, emphasizing personalized treatment strategies based on genetic and molecular profiling. Case studies will illustrate the impact of tailored therapies on patient care.

Track 04

Tumor Microenvironment and Cancer Progression

This session will investigate the interactions between tumor cells and their microenvironment, highlighting how these relationships influence cancer progression and metastasis. Presentations will cover both experimental and clinical insights into tumor biology.

Track 05

Translational Oncology: Bridging Research and Clinical Practice

This track will focus on the translation of laboratory findings into clinical applications, addressing the challenges and successes of moving from bench to bedside. Participants will discuss innovative approaches to enhance the efficacy of cancer therapies.

Track 06

Health Policy and Access to Cancer Care

This session will explore the impact of health policy on cancer treatment accessibility and quality of care. Experts will discuss strategies to improve healthcare delivery and address disparities in cancer treatment across populations.

Track 07

Emerging Trends in Cancer Biology

This track will highlight the latest research in cancer biology, focusing on novel pathways and mechanisms that drive tumorigenesis. Presentations will cover cutting-edge studies that may lead to new therapeutic targets.

Track 08

Combination Therapies in Oncology

This session will examine the rationale and effectiveness of combination therapies in cancer treatment. Researchers will present data on synergistic effects of combining different modalities, including chemotherapy, immunotherapy, and targeted therapies.

Track 09

Pediatric Oncology: Unique Challenges and Innovations

This track will address the specific challenges faced in pediatric oncology, including treatment side effects and long-term outcomes. Innovative approaches and recent advancements in the treatment of childhood cancers will be discussed.

Track 10

Clinical Trials: Design and Implementation in Oncology

This session will focus on the design and execution of clinical trials in oncology, emphasizing best practices and regulatory considerations. Participants will share insights on improving patient recruitment and retention in cancer studies.

Track 11

Future Directions in Cancer Research

This track will explore emerging trends and future directions in cancer research, including novel therapeutic approaches and technologies. Experts will discuss the potential impact of artificial intelligence and big data on oncology.